Concord Drugs Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Concord Drugs Quarterly Results    (CODL)

Here are the latest quarterly results of Concord Drugs. For more details, see the Concord Drugs financial fact sheet and Concord Drugs share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Concord Drugs Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m1331411091311821668284 
Other income Rs m00000000 
Turnover Rs m1331411091311821668284 
Expenses Rs m1241321011231721577676 
Gross profit Rs m99881094210 
Depreciation Rs m44443343 
Interest Rs m44434523 
Profit before tax Rs m211221364 
Tax Rs m00001090 
Profit after tax Rs m110121273 
Gross profit margin %7.16.27.56.05.35.650.611.8 
Effective tax rate %26.831.829.722.026.325.524.611.8 
Net profit margin %1.00.40.40.90.90.532.74.0 
Diluted EPS Rs 0.2 0.1 0.1 0.1 0.2 0.1 3.4 0.4  
Diluted EPS (TTM) Rs NA NA 0.6 0.5 0.5 0.5 3.9 4.2  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Pharmaceuticals Company Quarterly Results:   SOLARA ACTIVE PHARMA SCIENCES  RELISH PHARMA  LACTOSE INDIA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  

Compare CONCORD DRUGS With:   SOLARA ACTIVE PHARMA SCIENCES  RELISH PHARMA  LACTOSE INDIA  UNICHEM LAB  PROCTER & GAMBLE HEALTH  



Today's Market

Sensex Ends 364 Points Higher; Titan and Shree Cement Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Windlas Biotech IPO to Hit the Market on 4 August. Key Points to Know (Views On News)

Jul 31, 2021

Windlas Biotech IPO to open for subscription next week. Price band fixed at Rs 448-460.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

More Views on News

Most Popular

Make Startup Profits from Bluechip Stocks (Profit Hunter)

Jul 21, 2021

A 166-bagger stock can deliver even more gains in this decade.

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices (Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun (Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CONCORD DRUGS SHARE PRICE


Aug 2, 2021 (Close)

TRACK CONCORD DRUGS

  • Track your investment in CONCORD DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CONCORD DRUGS

CONCORD DRUGS - ACTAVIS COMPARISON

COMPARE CONCORD DRUGS WITH

MARKET STATS